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Abstract 27 
Exercise induces a mobilisation of CD8+ T lymphocytes (CD8TL) into peripheral blood. This 28 
response is largely confined to effector-memory CD8TLs: antigen experienced cells which have 29 
a strong tissue-homing and effector potential. This study investigated whether T cell memory 30 
phenotype also accounts for the CD8TL egress from peripheral blood following exercise. As 31 
latent Cytomegalovirus (CMV) infection is associated with a robust expansion in the number and 32 
proportion of effector-memory CD8TLs, we also investigated if CMV serostatus was a 33 
determinant of the CD8TL responses to exercise.  34 
Fourteen males (Mean age 35, SD ± 14 yrs), half of whom were CMV seropositive 35 
(CMV+), ran on a treadmill for 60 minutes at 80% OV& 2 max. Blood was collected at baseline 36 
(Pre), during the final minute of exercise (Ex60), and 15 (Post15) and 60 (Post60) minutes 37 
thereafter. CD8TL memory subsets were characterised by flow cytometry, using the cell-surface 38 
markers CD45RA, CD27, and CD28.  39 
The results confirmed that CD8TLs with an effector-memory phenotype 40 
(CD27!CD28!CD45RA+/!) exhibited the largest increase during exercise (+200% to +250%), 41 
and further showed that these cells exhibited the largest egress from blood 60 minutes post-42 
exercise (down to 40% of baseline values). Strikingly, the mobilisation and subsequent egress of 43 
total CD8TLs was nearly twice as large in CMV+ individuals. This effect appeared specific to 44 
CD8TLs, and was not seen for CD4+ T lymphocytes or total lymphocytes. This effect of CMV 45 
was largely driven by higher numbers of exercise-responsive effector-memory CD8TLs in the 46 
CMV+ participants.  47 
This is the first study to demonstrate that infection history is a determinant of immune 48 
responses to exercise.  49 
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1. Introduction 52 
 All mammals, including humans, have a remarkable capacity to acutely change the 53 
cellular composition of peripheral blood in response to psychological and physiological stressors 54 
(Dhabhar, 2000). For example, strenuous exercise causes a near-immediate mobilisation of 55 
lymphocytes into the blood, a process referred to as lymphocytosis (Gleeson and Bishop, 2005; 56 
McCarthy and Dale, 1988). This phenomenon is particularly marked for lymphocytes with a 57 
cytotoxic potential, such as Natural Killer cells, !" T lymphocytes, and CD8+ T lymphocytes 58 
(CD8TLs) (Anane et al., 2009). These subsets exhibit a high adrenergic receptor density and 59 
sensitivity, which in turn, regulates their detachment from vascular endothelium and release into 60 
the blood (Anane et al., 2009; Benschop et al., 1994; Dimitrov et al., 2010). Indeed, there is now 61 
conclusive evidence that stress and exercise-induced lymphocytosis is under the control of the 62 
sympathetic nervous system and the concomitant release of catecholamines (Benschop et al., 63 
1994; Dimitrov et al., 2010; Elenkov et al., 2000).  64 
One to two hours after high-intensity exercise, the lymphocytosis is followed by a 65 
lymphocytopenia whereby the numbers of circulating lymphocytes fall below baseline level 66 
(Gleeson and Bishop, 2005; McCarthy and Dale, 1988). Experimental studies in rodents suggest 67 
that this lymphocytopenia reflects extravasation of lymphocytes to selected peripheral tissues, 68 
such as the lungs, presumably part of enhanced immunosurveillance in front-line tissues (Krüger 69 
et al., 2008; Krüger and Mooren, 2007). Consistent with this model, recent studies in humans 70 
have shown that exercise preferentially mobilises a subset of memory CD8TLs that have a strong 71 
tissue migrating potential and the capacity to induce rapid effector responses (e.g., target killing) 72 
(Campbell et al., 2009; Simpson et al., 2008; Simpson et al., 2007a). It might therefore be 73 
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predicted that these tissue-migrating memory cells would preferentially egress from peripheral 74 
blood post-exercise, but there is currently no data to support this contention.  75 
 Subsets of CD8TLs have been identified on the basis of the combined expression of cell 76 
surface markers such as CD45RA, CD27, and CD28 (Appay et al., 2002; Appay et al., 2008; 77 
Hamann et al., 1997; Romero et al., 2007) (see Table 1). In our study we used two phenotypic 78 
profiles to define effector memory subpopulations; comparing CD45RA and CD27 expression, 79 
or CD27 and CD28 expression (see Table 1). CD45RA is one of the two isoforms of the 80 
leukocyte surface protein CD45R. This isoform is present on naïve T cells and replaced by the 81 
isoform CD45RO after antigenic recognition. However, CD45RA is re-expressed on a subset of 82 
so-called ‘revertant’ memory cells, and this CD45RA+CD27! phenotype is known to exhibit 83 
strong effector potential (such as the ability for rapid target killing, inflammatory cytokine 84 
production, and tissue migration, see Table 1). CD27 and CD28 are co-stimulatory and survival 85 
molecules that are co-expressed on naïve and early memory populations. However, during 86 
differentiation (i.e., a process characterised by the accumulation of effector functions), these 87 
markers are gradually lost and a CD27!CD28! phenotype defines a population of late 88 
differentiated effector memory cells. CD45RA+CD27! cells are themselves largely CD28! and 89 
there is therefore considerable overlap between these phenotypic profiles (Appay et al., 2008; 90 
Hamann et al., 1997; van Lier et al., 2003) 91 
 Individual differences in the proportions and numbers of the various CD8TL memory 92 
subsets are to a considerable extent determined by infection history (Chidrawar et al., 2009; 93 
Khan et al., 2002). For example, infection with Cytomegalovirus (CMV) causes a robust 94 
accumulation of late differentiated effector-memory CD8TLs, which are characterised by loss of 95 
CD27 and CD28 expression, as well as frequent ‘reversion’ to expression of the naïve CD45RA 96 
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isoform (Appay et al., 2002; van Lier et al., 2003). CMV is an endemic herpes virus which 97 
infects approximately 60% of western populations (Lubeck et al., 2010; Staras et al., 2006). In 98 
healthy individuals infection with CMV is usually asymptomatic and the virus remains latent in 99 
the body, but is believed to undergo intermittent reactivation (Stowe et al., 2007; Zanghellini et 100 
al., 1999). In view of research showing a selective mobilisation of effector memory CD8TLs 101 
with exercise (Campbell et al., 2009), we investigated if CMV seropositive individuals 102 
demonstrated an exaggerated CD8TL exercise-response as a consequence of the accumulation of 103 
late-differentiated/effector-memory CD8TLs. 104 
The aim of the current study was therefore to determine the pattern of egress within 105 
discrete CD8TL memory subsets following recovery from exercise and to compare this to the 106 
profile of mobilisation during exercise. Secondly, we aimed to determine if infection history is a 107 
determinant of this immune cell redistribution with a specific investigation of how CMV 108 
serostatus influences the magnitude and kinetics of CD8TL mobilisation. 109 
 110 
111 
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2. Methods 112 
2.1. Participants 113 
 Participants were fourteen healthy non-smoking men (mean age = 35, SD ± 14; BMI; 24 114 
± 3 kg.m-2), who were accustomed to vigorous endurance exercise and had a cardio-respiratory 115 
fitness ( OV& 2 max) within the 90th percentile for their age (Whaley et al., 2006). Participants 116 
provided informed consent, and the study was approved by the School of Sport and Exercise 117 
Sciences research ethics committee, of the University of Birmingham. 118 
 119 
2.2. Procedures 120 
 Participants visited the laboratory to undergo two graded exercise tests on a treadmill. 121 
The first exercise test measured OV& 2 max by running to volitional exhaustion, to enable the 122 
intensity of the exercise trial to be prescribed relative to the fitness of each participant (i.e., 80% 123 
of OV& 2 max). A second test assessed the relationship between oxygen consumption ( OV& 2) and 124 
four sub-maximal running speeds (range 8.2 -11.6 km"h-1) to calculate the speed to elicit 80% of 125 
OV& 2 max, using linear regression. Breath-by-breath measurements were recorded every 5 126 
seconds throughout both tests (Oxycon Pro, Jaegar, Germany), with heart rate monitored  127 
(RS200, Polar, Finland) and ratings of perceived exertion (RPE) (Borg, 1973) recorded during 128 
the final minute of each stage. In addition, participants had leisure time physical activity assessed 129 
using the international physical activity questionnaire (IPAQ) (Craig et al., 2003). IPAQ data 130 
was expressed as MET-minutes per week, where 1 MET (metabolic equivalent) is equal to 131 
resting metabolic rate (Ainsworth et al., 1993). 132 
 133 
2.3. Exercise trial 134 
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 One week after the preliminary tests, participants visited the laboratory for an exercise 135 
trial. Participants were instructed to refrain from exercising and drinking alcohol or caffeine 136 
during the day prior to the trial. After an overnight fast, participants reported to the laboratory 137 
between 06:00-07:00. Following a 15 minute rest, a baseline blood sample (Pre) was collected 138 
from forearm vein by an indwelling catheter, which was kept patent by flushing regularly with 139 
saline. 140 
 The baseline sample was followed by the exercise trial, which consisted of treadmill 141 
running at a speed to elicit 80% of OV& 2 max for 60 minutes. Breath-by-breath measurements, 142 
heart rate and RPE were recorded for periods of 5 minutes at regular intervals. Blood samples 143 
were collected during the final minute of exercise (Ex60), and again 15 minutes (Post15) and 60 144 
minutes (Post60) post-exercise. To address possible confounding of exercise results by diurnal 145 
variation in lymphocyte counts, seven participants also completed a control trial which involved 146 
sitting in the same room for 2 hours, with all measures collected in an identical manner to the 147 
exercise trial. The order of the two trials was counterbalanced. 148 
 149 
2.4. Flow cytometry 150 
 Blood was collected in ethylene-diamine-tetra-acetic acid (EDTA) vacutainer tubes 151 
(Becton-Dickinson, Oxford, UK) and samples were prepared within 3 hours of collection. 152 
Briefly, whole blood was incubated with the following monoclonal antibodies for 20 minutes at 153 
room temperature; CD45RA FITC, CD27 PE (Pharmingen, San Diego, USA), CD3 PerCP, CD4 154 
APC, CD8 APC-cy7 (BD Biosciences, San Jose, USA) and CD28 PE-cy7 (eBioscience, 155 
Hatfield, UK). Erythrocytes were lysed with FACS lysing solution (BD Biosciences, San Jose, 156 
USA) according to manufacturer instructions, and then centrifuged at 250 # g for 7 minutes. 157 
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Cells were re-suspended in 2% paraformaldehyde phosphate-buffered saline solution and stored 158 
in the dark at 4°C. Cells were read within 24 h on a six colour flow cytometer (BD FACS 159 
CANTO II, BD Biosciences), collecting 25,000 gated lymphocytes. The flow cytometer was 160 
regularly calibrated using Calibrite beads (BD Biosciences, San Jose, USA) and compensation 161 
adjustments were made prior to each run using single labelled antibody tubes. Data were 162 
analysed using FlowJo7 (Tree Star, Inc., Ashland, OR), and lymphocytes enumerated using a 163 
Coulter ACTdiff haematology analyser (Beckman-Coulter, High Wycombe, UK). 164 
 The lymphocyte population was gated on the forward versus side-scatter and further 165 
identified by CD8 expression in combination with CD3 (Campbell et al., 2008). CD8TL 166 
expression of CD45RA and CD27 was examined to identify naïve, central memory, effector 167 
memory, and CD45RA+ effector memory sub-populations as described elsewhere (Campbell et 168 
al., 2009; Hamann et al., 1997; Romero et al., 2007). CD8TLs were also examined for CD27 and 169 
CD28 expression to identify early, intermediate and late sub-populations, as described by Appay 170 
et al. (2002). 171 
 172 
2.5. CMV serostatus 173 
 Plasma from baseline blood samples was assayed for IgG antibodies to CMV using a 174 
commercially available enzyme-linked immunosorbent assay (ELISA) (Biocheck, Inc. CA, 175 
USA) according to manufacturer instructions.  176 
 177 
2.6. Statistical analyses 178 
 Data were inspected for normal distribution using the Kolmogrov Smirnov test. Non-179 
normally distributed data were transformed logarithmically. Responses to exercise were 180 
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examined using repeated-measures Analyses of Variance (ANOVAs), with age and baseline cell 181 
count included as covariates where appropriate (Jennings and Stine, 2007). Differences between 182 
individual time points were examined using post-hoc paired samples t-tests. To confirm our 183 
parametric analyses, equivalent non-parametric tests were used. Statistical significance was 184 
accepted at the p <.05 level. Data are presented as means ± standard error of the mean (SEM) 185 
unless otherwise stated. Data were analysed using SPSS statistical package version 18.0 for 186 
Windows (SPSS Inc, USA). 187 
 188 
189 
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3. Results 190 
All participants completed the exercise trial successfully. Table 2 compares OV& 2, energy 191 
expenditure, heart rate, and perceived exertion during treadmill running with seated rest during 192 
the control trial 193 
 194 
3.1. Leukocyte subsets 195 
 Table 3 shows the summary data for leukocyte subsets. Exercise was associated with an 196 
acute leukocytosis, whereby total leukocyte count increased by +85% during exercise and 197 
remained elevated +22% above baseline values at 60 minutes post-exercise. The leukocytosis 198 
during exercise was mainly driven by a mobilisation of lymphocytes (+113%) and granulocytes 199 
(+66%), while 60 minutes after the exercise bout, lymphocyte numbers fell below baseline levels 200 
(!25%), accompanied by a secondary mobilisation of granulocytes (+67%) (See Table 3). The 201 
biphasic lymphocyte response was replicated in both CD4+ T lymphocytes (CD4TLs) and 202 
CD8TLs, although it was more marked for the latter (see Table 3).  203 
 204 
3.2. CD8TL subsets during exercise 205 
 Replicating previous findings (Campbell et al., 2009), exercise resulted in a significantly 206 
larger mobilisation of CD8TL effector-memory (+207%) and CD45RA+ effector-memory cells 207 
(+239%), as compared to central memory (+108%) or naïve CD8TLs (+58%) (paired samples t-208 
tests, all t (13) > 4.4,  p <.01; see Figure 1A). Identifying CD8TL subsets on the basis of CD27 209 
and CD28 expression (yielding early, intermediate, and late differentiated cells, see Table 1), 210 
showed that phenotypically late-differentiated cells exhibited a larger increase (+265%) as 211 
compared to both intermediate (+154%) and early differentiated cells (+67%). Intermediate 212 
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differentiated cells, in turn, showed a larger increase than CD8TL with an early differentiated 213 
phenotype (paired samples t-tests, all t (13) > 5.0, p <.01; see Figure 1C).  214 
 215 
3.3. CD8TL subsets post-exercise 216 
 Figure 1B and 1D show that the pattern of CD8TL mobilisation seen during exercise was 217 
broadly mirrored with the egress 60 minutes post-exercise. Specifically, CD45RA+ effector 218 
memory cells showed a significantly larger decrease (!60%) than effector memory cells (!38%), 219 
which both showed a larger decrease than central memory (!30%) and naïve CD8TLs (!29%) 220 
(paired samples t-tests, all t (13)  > 2.4, p <.03). Identifying CD8TL subsets on the basis of CD27 221 
and CD28 expression (see Table 1) revealed that late differentiated cells had the greatest fall in 222 
numbers (!60%) compared to cells with an intermediate (!52%) or early (!28%) phenotype 223 
(paired samples t-tests, all t (13) > 4.7, p <.001; see Figure 1D). 224 
 225 
3.4. Control trial 226 
Participants who took part in the control trial (n = 7, condition-order counterbalanced) did 227 
not exhibit any significant changes in CD8TL subpopulations or any other leukocyte subset (all 228 
pair-wise comparisons p >.10). 229 
 230 
3.5. CMV serostatus and lymphocyte responses to exercise 231 
 Repeated measures ANOVA yielded a significant time (Pre, Ex60, Post15, Post60) by 232 
serostatus interaction (F (3, 33) = 6.3, p <.05, $2 = 0.37, adjusted for age) for CD8TL responses 233 
(Figure 2A). Post-hoc analyses revealed that this effect was largely driven by a ~2-fold larger 234 
increase in CD8TLs during exercise (F (1, 11) = 5.3, p <.05, $2 = 0.33), as well as a ~2-fold larger 235 
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post-exercise egress (F (1, 11) = 5.2, p <.05, $2 = 0.32) in CMV+ individuals (Figure 2C and Figure 236 
2D; all analyses adjusted for age). Comparable results were obtained when using non-parametric 237 
statistical tests (Wilcoxon signed-rank test). As shown in Table 4, CMV serostatus was unrelated 238 
to age, BMI, leisure time physical activity, fitness, maximum heart rate, or any of the measures 239 
of exercise performance. Adjustment for these parameters statistically did not attenuate the 240 
observed difference in CD8TL mobilisation. CMV serostatus was unrelated to CD4TL responses 241 
(Figure 2B) or total lymphocyte responses (data not shown) (serostatus by time interactions for 242 
CD4TL and lymphocytes respectively; F (3, 33) = 0.4, p >.7 and F (3, 33) = 1.8, p >.17, analyses 243 
adjusted for age). 244 
 245 
3.6. CMV serostatus and CD8TL subset responses to exercise  246 
 The differential CD8TL response described above was anticipated because positive CMV 247 
serostatus is associated with higher numbers of exercise-responsive late-differentiated/effector-248 
memory subsets (van Lier et al., 2003). This observation was replicated in the current study: 249 
compared to CMV! individuals, those who were CMV+ had a ~6-fold greater number of 250 
CD45RA+ effector memory (t (12) = !3.3, p <.01) and a ~6-fold greater number of late 251 
differentiated CD8TLs (t (12) = !3.4, p<.01; independent samples t-tests). 252 
Figure 3 displays the response of individual CD8TL subpopulations, as identified on the 253 
basis of CD45RA and CD27 expression (see Table 1). Repeated measures ANOVA confirmed 254 
that serostatus was associated with a larger increase in effector memory cells (CD45RA!CD27!) 255 
(serostatus by time interaction; F (1, 11) = 5.3, p < .05, $2 = 0.33) and CD45RA+ effector memory 256 
cells (CD45RA+CD27!) (serostatus by time interaction; F (1, 11) 15.2, p < .01, $2 = 0.58) (all 257 
analyses adjusted for age). The magnitude of post-exercise lymphocytopenia of these subsets 258 
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was similarly moderated by CMV serostatus (serostatus by time interactions: for effector 259 
memory cells; F (1, 11) = 8.5, p <.05, $2 = 0.43; for CD45RA+ effector memory cells; F (1, 11) = 8.5, 260 
p <.05, $2 = 0.43, both analyses adjusted for age). CMV serostatus was not associated with 261 
differential mobilisation or egress of naïve or central memory cells (serostatus by time 262 
interactions F (1, 11) < 3.5, p >.2, adjusted for age).  263 
To test if the larger memory CD8TL responses in CMV+ individuals were explained by 264 
higher basal numbers of these cells, the above analyses were repeated with statistical adjustment 265 
for initial values (i.e., entering baseline cell count as a covariate in ANOVAs). After this 266 
correction, the interaction effects for effector memory and CD45RA+ effector memory cells 267 
during exercise disappeared (F (1, 10) < 4.5, p > .06). Similarly, the augmented post-exercise 268 
decrease in CD45RA+ effector memory cells was no longer statistically different between CMV+ 269 
and CMV% individuals after adjusting for baseline cell count (F (1, 10) = 3.0, p = .11, adjusted for 270 
age and initial values), although the larger post-exercise decrease in effector memory cells seen 271 
for CMV+ individuals remained significant after adjustment (F (1, 10) = 6.2, p <.05, $2 = 0.38, 272 
adjusted for age and initial values).  273 
 Shown in Figure 4, a comparable pattern of results was found when memory subsets were 274 
identified on the basis on CD27 and CD28 expression (see Table 1), demonstrating a 275 
significantly larger mobilisation of late differentiated cells in CMV+ individuals (serostatus by 276 
time interaction; F (1, 11) = 6.9, p < .05, $2= 0.39, adjusted for age), which was still apparent after 277 
controlling for baseline cell count (F (1, 10) 5.5, p < .05, $2= 0.355), although the post-exercise 278 
egress did not reach statistical significance (serostatus by time interaction; F (1, 11)  = 2.7, p =.13, 279 
$2= 0.20, adjusted for age). CMV serostatus did not significantly moderate the responses of 280 
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intermediate or early differentiated cells (serostatus by time interactions; F (1, 11) <3.8, p > .08; all 281 
analyses adjusted for age). 282 
283 
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4. Discussion  284 
 Recent studies have demonstrated a high specificity in the mobilisation of CD8TL 285 
subsets during exercise, whereby a subpopulation of memory cells, i.e., those with strong tissue-286 
migrating capacity and effector potential, preferentially increase in the peripheral blood 287 
(Campbell et al., 2009; Simpson et al., 2008; Simpson et al., 2007a). In line with the assumption 288 
that this mobilisation is part of an immune surveillance response, we wondered if these memory 289 
cells might also show preferential egress from peripheral blood in the post-exercise period. Our 290 
results confirmed this expectation, showing a !60% decrease in late differentiated/effector-291 
memory cells, compared to a !25% and !29% fall in total lymphocytes and naïve CD8TLs 292 
respectively. Thus, with exercise, cells that are relevant to immune surveillance, i.e., those with 293 
proven capacity to initiate immediate effector responses such as target killing, are preferentially 294 
redeployed into and out of peripheral blood. As their action is most likely to be required in tissue 295 
rather than peripheral blood, it seems probable that the egress, rather than peripheral release, is 296 
the most significant aspect of this evolved response. 297 
While the mechanisms responsible for exercise-induced CD8TL mobilisation are well-298 
researched, less is known about the post-exercise egress. Some researchers have contended that 299 
the fall in cell number is caused by exercise-induced apoptosis (Mars et al., 1998; Mooren et al., 300 
2002; Mooren et al., 2004). However, both animal and human evidence provide only limited 301 
support for this idea (Dhabhar et al., 1995, 1996). For example, although following exercise 302 
lymphocyte numbers fall to less than 50% of baseline levels (Hansen et al., 1991; Shephard and 303 
Shek, 1999), only <10% of lymphocytes undergo post-exercise apoptosis (Mars et al., 1998; 304 
Mooren et al., 2002; Mooren et al., 2004). Moreover, exercise-induced lymphocytopenia has 305 
been observed without evidence for apoptosis (Simpson et al., 2007b; Tanimura et al., 2008). 306 
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More support exists for the idea that the post-exercise fall in cell numbers is due to lymphocyte 307 
homing into peripheral tissues. This migration is postulated to be part of an immune surveillance 308 
response (Dhabhar, 2000, 2002; Krüger et al., 2008; Krüger and Mooren, 2007). Cortisol has 309 
been proposed as a neuro-endocrine mediator of this lymphocytopenia (Fauci, 1976; McCarthy 310 
and Dale, 1988; Onsrud and Thorsby, 1981). However, recent evidence indicates that this is 311 
unlikely to explain enhanced egress of late differentiated cells as seen in our study: Dimitrov and 312 
co-workers (2009) showed that although cortisol infusion caused lymphocytopenia, this response 313 
was restricted to naïve and lymphoid-homing (CD62L+) CD8TLs, and that differentiated 314 
effector-memory cells were unaffected. It is possible that the subsequent egress may reflect 315 
delayed effects of adrenergic stimulation (Ali et al., 2007), which would be consistent with the 316 
observation that this delayed decrease so closely parallels the pattern of catecholamine dependent 317 
mobilisation. 318 
The CD8TL memory subsets that showed the strongest responses to exercise are known 319 
to be selectively increased by latent CMV infection (Appay et al., 2002; van Lier et al., 2003). 320 
Significantly, these differentiated memory CD8TL subsets are also known to express higher 321 
levels of the #2-adrenergic receptor, possibly explaining their higher sensitivity to exercise 322 
(Dimitrov et al., 2010; Holmes et al., 2005; Karaszewski et al., 1991). Based on these data, we 323 
anticipated that CMV serostatus would moderate CD8TL responses to exercise. The results 324 
indeed showed that both the mobilisation and post-exercise egress was nearly twice as large in 325 
CMV+ individuals, as compared to CMV% individuals. Further analyses confirmed that this 326 
augmentation was largely explained by the higher numbers of differentiated memory cells in 327 
CMV+ individuals. For example, the number of CD45RA+CD27% CD8TLs was ~6-fold higher in 328 
CMV+ participants, which is comparable with what has been reported in the literature 329 
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(Chidrawar et al., 2009; Khan et al., 2002; Weinberger et al., 2007). Post-hoc analyses excluded 330 
that exercise intensity explained the response differences, as none of the performance indices 331 
were related to serostatus (i.e., OV& 2, energy expenditure, heart rate, and RPE). Further analyses 332 
also showed that CMV serostatus was unrelated to age, BMI, leisure time physical activity, 333 
fitness, and maximum heart rate. To our knowledge, this is the first study to demonstrate that 334 
infection history is a determinant of immunological responses to exercise. 335 
CD4TL responses to exercise were not moderated by CMV serostatus. This was not 336 
unexpected as CD4TLs and their memory subsets are, compared to CD8TLs, generally less 337 
responsive to exercise (Campbell et al., 2009), and the effects of CMV infection on the 338 
composition of the CD4TL memory pool are modest (Fletcher et al., 2005; Khan et al., 2002; 339 
Pourgheysari et al., 2007; Wikby et al., 2002). Although no further lymphocyte subsets were 340 
examined, the null-finding for CD4TLs as well as for total lymphocytes suggests that the 341 
observed effects of serostatus are selective for CD8TLs. 342 
What are possible implications of the current findings? Considering that the late 343 
differentiated CD8TLs which egress from peripheral blood have a strong tissue homing and 344 
inflammatory capacity, it could be argued that amplification of this response may promote 345 
protective immune surveillance, and thereby improve clearance of infection and vaccine 346 
responses (Edwards et al., 2007; Edwards et al., 2006). Conversely, it might be argued that 347 
enhanced mobilisation and tissue migration of CD8TLs may have harmful effects by aggravating 348 
inflammatory processes (Dhabhar, 2000, 2002). This may, for example, be relevant in 349 
atherosclerosis whereby IFN-! producing CD8TLs accumulate in atherosclerotic plaques (de 350 
Boer et al., 2003; de Boer et al., 1999; Gewaltig et al., 2008). Interestingly, CMV also facilitates 351 
transmigration of memory CD8TLs via infection of endothelial cells (Burns et al., 1999; Craigen 352 
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et al., 1997), and the exaggerated CD8TL mobilisation in CMV+ individuals might thus further 353 
promote cardiovascular disease risk (Strandberg et al., 2003). Moreover, as most cardiovascular 354 
diseases are associated with enhanced sympathetic activity (Fisher et al., 2009), it is conceivable 355 
that the cardio-protective effects of &-antagonists may be stronger in CMV+ individuals via 356 
blunting of inflammatory CD8TL recruitment (Kuhlwein et al., 2001; Mills et al., 1999). 357 
Another potentially significant implication is that the current observations identify CMV 358 
serostatus as a possible mediator or confounder in exercise and behavioural immunology. For 359 
example, increased infection rates among athletes following endurance exercise events (the so-360 
called ‘open window hypothesis’) have in part, been attributed to decreased numbers and 361 
functional capacity of peripheral blood cells post-exercise (Nieman, 1995; Pedersen and 362 
Hoffman-Goetz, 2000). It now seems likely that individual differences in the magnitude of 363 
lymphocytopenia, and possibly alterations in cell function post-exercise, are at least in part 364 
related to infection history. The same would apply to research linking exercise- (and possibly 365 
stress-) induced lymphocyte redeployment to health status (e.g., hypertension) or demographics 366 
(e.g., age) (Ceddia et al., 1999; Mazzeo et al., 1998; Mills et al., 2003; Shinkai et al., 1998). This 367 
caveat seems to be strengthened by the association of positive CMV serostatus with ethnicity, 368 
increased age, lower socio-economic status (Dowd and Aiello, 2009; Lubeck et al., 2010; Staras 369 
et al., 2006), as well as health outcomes such as atherosclerotic risk and susceptibility to 370 
infection (Dumortier et al., 2008; Hadrup et al., 2006; Olsson et al., 2000; Streblow et al., 2008; 371 
Strindhall et al., 2007). Taking a broader perspective, the fact that CMV infection expands a 372 
CD8TL population which expresses higher levels of the &2-adrenergic receptor (Dimitrov et al., 373 
2009; Holmes et al., 2005; Karaszewski et al., 1991) has general relevance to neuro-endocrine 374 
immunology. For example, differentiated CD8TLs exhibit unique immunological features, such 375 
20 
 
as increased IFN-! production and cytotoxicity (Hamann et al., 1997; Sallusto et al., 1999). 376 
These functional characteristics may likewise become differentially affected by exercise, and 377 
possibly stress, in CMV+ individuals.  378 
Regarding the limitations of the present study, an important target for future research 379 
would be to determine if the enhanced CD8TL response to exercise is attributable to mobilisation 380 
of CMV-specific CD8TLs only, or that effector-memory CD8TLs with other antigen-381 
specificities are similarly mobilised. Antigen-specific T lymphocytes can be identified using 382 
tetramers, which are synthetic HLA-molecule analogues tagged with an antigen-peptide, that are 383 
capable of binding virus-specific T cell receptors. To be able to answer this question 384 
conclusively, one would need to use tetramers for all immunogenic CMV epitopes and for all 385 
HLA types; we are not aware of a single laboratory that has access to such tetramer diversity. A 386 
second limitation of this study is that it is uncertain to what extent our observations would 387 
generalise to other latent micro-organisms. A number of viruses are known to affect composition 388 
of the lymphocyte pool, but these effects are different from those of CMV. For example, it seems 389 
unlikely EBV infection would have the same effect as CMV, because EBV predominantly 390 
increases the number of (exercise unresponsive) central-memory cells (Appay et al., 2008; van 391 
Lier et al., 2003). Similar to CMV, HIV is known to increase the number of effector-memory 392 
cells (Appay et al., 2008; van Lier et al., 2003), which suggests that this infection may also alter 393 
CD8TL responses to exercise. A possible third limitation is that participants were all physically 394 
fit. Unfit individuals have been shown to exhibit larger CD8TL responses to exercise compared 395 
those who are fit (Hong et al., 2004; Hong et al., 2005; Mills et al., 2006), and thus it is 396 
conceivable that the effects of CMV serostatus may be weakened or amplified by fitness.  397 
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 In conclusion, the results of the present study have shown that CD8TL mobilisation and 398 
egress in response to intensive exercise are both driven by differentiated effector-memory cells. 399 
Additionally, we have shown, for the first time, that infection history can substantially modulate 400 
this bimodal CD8TL response to exercise by altering the composition of the memory pool. 401 
  402 
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Figure legends 619 
Figure 1 620 
Percentage change ('%) in cell numbers of CD8TLs sub-populations, during exercise (Ex60; A 621 
and C), and at 1-hour post-exercise (Post60; B and D). Panel A and B show subsets identified by 622 
CD45RA and CD27 expression. Panel C and D show subsets identified by CD27 and CD28 623 
expression. Naïve CD45RA+CD27+. Central memory (CM) CD45RA+CD27-. Effector memory 624 
(EM) CD45RA-CD27-. CD45RA+ Effector memory (RAEM) CD45RA+CD27-. Early 625 
CD27+CD28!. Inter CD27+CD28!. Late CD27!CD28!. a p<.001compared to naïve and CM. b 626 
p<.01compared naïve. c compared to EM. d compared to naïve, p<.03. e compared to CM p<.01. 627 
f compared to early p<.001. g compared to inter p<.01 (paired samples t-tests). 628 
 629 
Figure 2 630 
Changes in A) CD8TLs (cells/(l). B) CD4TLs (cells/(l). C) Percentage change ('%) in CD8TL 631 
and CD4TL numbers during exercise (Ex60) D) Percentage change ('%) in CD8TL and CD4TL 632 
numbers 60-minutes post-exercise (Post60). *** p < .001; main effects of time, results of 633 
repeated measures ANOVA (comparison with baseline values). * p < .05, comparing CMV– with 634 
CMV+ (ANOVA) 635 
 636 
Figure 3 637 
Changes in CD8TL sub-populations (cells/(l) identified by CD45RA and CD27 expression. A) 638 
Naïve CD8TLs (CD45RA+CD27+). B) Central memory CD8TLs (CM; CD45RA+CD27!). C) 639 
Effector memory CD8TLs (EM; CD45RA!CD27!). D) CD45RA+ effector memory CD8TLs 640 
(RAEM; CD45RA+CD27!). *** p < .001; ** p < .01; main effects of time, results of repeated 641 
29 
 
measures ANOVA (comparison with baseline values). See text for ‘time by serostatus’ 642 
interactions. 643 
 644 
Figure 4 645 
Changes in CD8TL sub-populations (cells/(l) identified by CD27 and CD28 expression. A) 646 
Early CD8TLs (CD27+CD28!). B) Intermediate CD8TLs (CD27+CD28!). C) Late CD8TLs 647 
(CD27!CD28!). *** p < .001; ** p < .01; main effects of time, results of repeated measures 648 
ANOVA (comparison with baseline values). See text for ‘time by serostatus’ interactions. 649 
 650 
Table legends 651 
Table 1 652 
Phenotypic identification and functional properties of CD8TL (CD3+CD8+) subsets  653 
 654 
Table 2 655 
Physiological demands of the exercise and control trials (mean ± SD). 656 
*** p < .001 Comparing exercise with control trial (independent samples t-test) 657 
RPE; ratings of perceived exertion  658 
 659 
Table 3 660 
Leukocyte subsets before (Pre), after 60 minutes of exercise (EX60), and 15 minutes (POST15) 661 
and 60 minutes (POST60) post exercise (mean ± SD). 662 
*** p< .001, ** p< .01, * p< .05,  compared to Pre (paired samples t-test) 663 
# Age as a covariate  664 
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 665 
Table 4 666 
Characteristics of CMV seropositive and seronegative participants (mean ± SD). No significant 667 
group differences were observed (p>.10, independent samples t-test). 668 
a Leisure Time Physical Activity, as assessed by the international physical activity questionnaire 669 
(IPAQ).  670 
b Data are medians (min-max), differences assessed using a Mann-Whitney U Test. 671 
 672 
 
Turner. CMV amplifies CD8T cell responses to exercise  
 
Table 1.  Phenotypic identification and functional properties of CD8TL (CD3+CD8+) subsets  
Cell description Identification Migration 
preference 
Effector 
potential 
Reference 
Naïve CD45RA+CD27+ Lymphoid tissue ! Hamann et al. 1997; Romero et al 2007 
Central memory CD45RA+CD27! Lymphoid tissue ! Hamann et al. 1997; Romero et al 2007 
Effector memory CD45RA!CD27! Peripheral tissue + Hamann et al. 1997; Romero et al 2007 
CD45RA+ effector memory CD45RA+CD27! Peripheral tissue ++ Hamann et al. 1997; Romero et al 2007 
Early CD27+CD28+ Lymphoid tissue ! Appay et al. 2002 
Inter CD27+CD28! Peripheral tissue + Appay et al. 2002 
Late CD27!CD28! Peripheral tissue ++ Appay et al. 2002 
 
 
 
Turner. CMV amplifies CD8T cell responses to exercise  
 
Table 2. Physiological demands of the exercise and control trials (mean ± SD) 
 
 Exercise Control 
 n = 14 n = 7 
OV& 2 (ml!kg-1!min-1) 45.6  ± 3.3*** 3.6 ± 0.5 
OV& 2 (% OV& 2max) 78.7  ± 1.9*** 6.4  ± 1.1 
Energy expenditure (kcal) 1011.0 ± 85.4***  80.4 ± 13.8 
Heart rate (bpm) 162  ± 13*** 51  ± 7 
Heart rate (% max) 88.0  ± 4.4*** 28.9  ± 3.4 
RPE 14 ± 2*** 6 ± 0 
 
*** p < .001 Comparing exercise with control trial (independent samples t-test) 
RPE; ratings of perceived exertion  
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Table 3.  Leukocyte subsets before (Pre), after 60 minutes of exercise (EX60), and 15 minutes (POST15) and 60 minutes (POST60) 
post exercise (mean ± SD) 
 
Cells x 109/L Pre EX60 POST15 POST60 Main effects of time # 
Leukocytes 6.29 ± 1.18 11.66 ± 3.13*** 8.19 ± 3.01*** 7.73 ± 3.51*** F(3, 33) = 15.8; p<.001 
Lymphocytes 2.59 ± 0.59 5.51 ± 1.82*** 2.94 ± 1.20 1.93 ± 0.94*** F(3, 33) = 150.0; p<.001 
Monocytes 0.53 ± 0.19 0.89 ± 0.41 0.54 ± 0.25 0.51 ± 0.23 F(3, 33) = 0.4; p=NS 
Granulocytes 3.17 ± 0.92  5.26 ± 2.10*** 4.71 ± 1.63*** 5.29 ± 2.15** F(3, 33) = 16.9; p<.001 
CD4TLs 1.09 ± 0.36 1.65 ± 0.81*** 1.15 ± 0.63 0.86 ± 0.47*** F(3, 33) = 57.9; p<.001 
CD8TLs 0.63 ± 0.24 1.33 ± 0.60*** 0.71 ± 0.29* 0.40 ± 0.16*** F(3, 33) = 62.2; p<.001 
 
*** p< .001, ** p< .01, * p< .05,  compared to Pre (paired samples t-test) 
 
# Age as a covariate  
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Table 4. Characteristics of CMV seropositive and seronegative participants (mean ± SD). No 
significant group differences were observed (p>.10, independent samples t-test). 
 
 CMV+ CMV! 
 n = 7 n = 7 
Subject characteristics at baseline   
Age (years) 34.5 ± 12.0 33.7 ± 15.9 
BMI (kg"m-2) 24.1  ± 3.6 23.3 ± 1.4 
LTPAa (Median MET"min"week-1)b 3960 (2853-4850) 2880 (1080-7290) 
Measured OV& 2 max 58.2 ± 5.1  57.8 ± 3.8 
Maximum heart rate at OV& 2 max (bpm) 181 ± 10 188 ± 9 
Exercise trial results   
OV& 2 (ml"kg-1"min-1) 46.0 ± 3.6 45.1 ± 3.2 
Energy expenditure (kcal) 1040.16 ± 82.44 981.77 ± 83.80 
Heart rate (bpm) 159 ± 11 166 ± 14 
RPE 13 ± 1 14 ± 2 
 
a Leisure Time Physical Activity, as assessed by the international physical activity questionnaire 
(IPAQ).  
b Data are medians (min-max), differences assessed using a Mann-Whitney U Test. 
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